Background: Uveal melanoma is the most common primary intraocular malignancy among
adults. It is, nevertheless, a rare disease, with an incidence of approximately one case per …

Uveal melanoma is the most prevalent primary intraocular tumour in adults with the
incidence between five and six cases per million people in the United States and Europe …

No standard treatment has been established for metastatic uveal melanoma (mUM).
Immunotherapy is commonly used for this disease even though UM has not been included …

Abstract Purpose of Review Uveal melanoma is a distinct subset of melanoma with a biology
and treatment approach that is unique from that of cutaneous melanoma. Here we will …

Introduction Uveal melanoma (UM) is the most common intraocular cancer and represents a
discrete subtype of melanoma. Metastatic disease, which occurs in half of patients, has a …

Uveal melanoma, a rare subset of melanoma, is the most common primary intraocular
malignancy in adults. Despite effective primary therapy, nearly 50% of patients will develop …

Simple Summary Uveal melanoma is the most common primary intraocular malignancy in
adults. Although it can be controlled locally, half of the patients still develop metastases. To …

PURPOSE Metastatic uveal melanoma has poor overall survival (OS) and no approved
systemic therapy options. Studies of single-agent immunotherapy regimens have shown …

Uveal melanoma (UM) is the most common intraocular malignancy in adults and shows a
high rate of metastatic spread. As randomized clinical trials with immune checkpoint …

Uveal melanomas (UM s) are a rare form of cancer with clinical and pathological
characteristics distinct from cutaneous melanomas. Ipilimumab has shown efficacy and …